Medical News Today -
3 Nov 2013 10:00
Glioblastoma multiforme (GBM), the brain cancer that killed Sen. Edward Kennedy and kills approximately 13,000 Americans a year, is aggressive and incurable. Now a Northwestern University research team is the first to demonstrate delivery of a drug that turns off a critical gene in this complex cancer, increasing survival rates significantly in animals with the deadly disease. The novel therapeutic, which is based on nanotechnology, is small and nimble enough to cross the blood-brain barrier and...
Share this Article